Anti-Pseudomonas aeruginosa serotype 5c antibody [SD6930] (ab69232)
Key features and details
- Mouse monoclonal [SD6930] to Pseudomonas aeruginosa serotype 5c
- Suitable for: ELISA, ICC/IF
- Reacts with: Pseudomonas aeruginosa
- Isotype: IgG1
Overview
-
Product name
Anti-Pseudomonas aeruginosa serotype 5c antibody [SD6930] -
Description
Mouse monoclonal [SD6930] to Pseudomonas aeruginosa serotype 5c -
Host species
Mouse -
Tested applications
Suitable for: ELISA, ICC/IFmore details -
Species reactivity
Reacts with: Pseudomonas aeruginosa -
Immunogen
Tissue, cells or virus corresponding to Pseudomonas aeruginosa serotype 5c. Pseudomonas aeruginosa serotype 5c (whole organism)
-
General notes
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles. -
Storage buffer
Preservative: 0.065% Sodium azide
Constituent: PBS -
Concentration information loading...
-
Purity
Protein A purified -
Clonality
Monoclonal -
Clone number
SD6930 -
Myeloma
Sp2/0 -
Isotype
IgG1 -
Research areas
Associated products
-
Compatible Secondaries
-
Isotype control
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab69232 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
ELISA |
Use at an assay dependent dilution.
|
|
ICC/IF | (1) |
Use at an assay dependent dilution.
|
Notes |
---|
ELISA
Use at an assay dependent dilution. |
ICC/IF
Use at an assay dependent dilution. |
Target
-
Relevance
Pseudomonas aeruginosa is Gram-negative, aerobic, rod-shaped bacteria with unipolar motility. An opportunistic human pathogen, P. aeruginosa is also an opportunistic pathogen of plants. P. aeruginosa bacteria are clinically important because they are resistant to most antibiotics and they are capable of surviving in conditions that few other organisms can tolerate. Pseudomonas is often encountered in hospital and clinical work because it is a major cause of hospital acquired (nosocomal) infections. Its main targets are immunocompromised individuals, burn victims, and individuals on respirators or with indwelling catheters. Additionally, these pathogens colonize the lungs of cystic fibrosis patients. P. aeruginosa is often identified by its pearlescent appearance and grape-like odor in vitro. Definitive clinical identification of P. aeruginosa includes identifying the production of both pyocyanin and fluorescein as well as its ability to grow at 42°C. P. aeruginosa is capable of growth in diesel and jet fuel, where it is known as hydrocarbon utilizing microorganisms (or "HUM bugs"), causing microbial corrosion. It creates dark gellish mats sometimes improperly called "algae". -
Alternative names
- P. aeruginosa antibody
- Pseudomonas aeruginosa antibody
Protocols
Datasheets and documents
-
SDS download
-
Datasheet download
References (3)
ab69232 has been referenced in 3 publications.
- Jun JI & Lau LF CCN1 is an opsonin for bacterial clearance and a direct activator of Toll-like receptor signaling. Nat Commun 11:1242 (2020). PubMed: 32144270
- Vila-Farrés X et al. Combating virulence of Gram-negative bacilli by OmpA inhibition. Sci Rep 7:14683 (2017). ICC/IF . PubMed: 29089624
- Pan CY et al. Epinecidin-1 has immunomodulatory effects, facilitating its therapeutic use in a mouse model of Pseudomonas aeruginosa sepsis. Antimicrob Agents Chemother 58:4264-74 (2014). PubMed: 24820078